{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=recombinant+viral+vaccine+therapy&page=3", "query": { "intervention": "recombinant viral vaccine therapy", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 190, "total_pages": 19, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=recombinant+viral+vaccine+therapy&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=recombinant+viral+vaccine+therapy&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-08T18:12:08.999Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00004579", "title": "A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV Infections", "HIV Seronegativity" ], "interventions": [ { "name": "gp160 MN/LAI-2", "type": "BIOLOGICAL" }, { "name": "ALVAC-HIV MN120TMG (vCP205)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Walter Reed Army Institute of Research (WRAIR)", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": null, "start_date": "1998-04", "completion_date": null, "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-10-08T18:12:08.999Z", "location_count": 1, "location_summary": "Rockville, Maryland", "locations": [ { "city": "Rockville", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00004579" }, { "nct_id": "NCT07808697", "title": "A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of Age", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "SARS-CoV-2" ], "interventions": [ { "name": "mRNA-1283", "type": "BIOLOGICAL" }, { "name": "mRNA-1273", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "ModernaTX, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "11 Years", "sex": "ALL", "summary": "6 Months to 11 Years" }, "enrollment_count": 300, "start_date": "2026-09-01", "completion_date": "2029-08-30", "has_results": false, "last_update_posted_date": "2026-09-09", "last_synced_at": "2026-10-08T18:12:08.999Z", "location_count": 13, "location_summary": "Ontario, California • Miami, Florida • Miami Lakes, Florida + 9 more", "locations": [ { "city": "Ontario", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami Lakes", "state": "Florida" }, { "city": "Tamarac", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07808697" }, { "nct_id": "NCT03207750", "title": "This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rotavirus Infection", "Rotavirus Vaccines" ], "interventions": [ { "name": "Rotarix", "type": "BIOLOGICAL" }, { "name": "Pediarix", "type": "BIOLOGICAL" }, { "name": "Hiberix", "type": "BIOLOGICAL" }, { "name": "Prevenar 13", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 1280, "start_date": "2017-09-14", "completion_date": "2019-03-01", "has_results": true, "last_update_posted_date": "2020-12-29", "last_synced_at": "2026-10-08T18:12:08.999Z", "location_count": 47, "location_summary": "Birmingham, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 40 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Daly City", "state": "California" }, { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03207750" }, { "nct_id": "NCT00000943", "title": "A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Tetanus Toxoid Vaccine", "type": "BIOLOGICAL" }, { "name": "Hepatitis A Vaccine (Inactivated)", "type": "BIOLOGICAL" }, { "name": "HIV-1 Immunogen", "type": "BIOLOGICAL" }, { "name": "Hepatitis B Vaccine (Recombinant)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": null, "completion_date": "2005-11", "has_results": false, "last_update_posted_date": "2021-10-29", "last_synced_at": "2026-10-08T18:12:08.999Z", "location_count": 2, "location_summary": "Iowa City, Iowa • New York, New York", "locations": [ { "city": "Iowa City", "state": "Iowa" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000943" }, { "nct_id": "NCT03620162", "title": "A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumococcal Infections" ], "interventions": [ { "name": "Prevnar 13™", "type": "BIOLOGICAL" }, { "name": "V114", "type": "BIOLOGICAL" }, { "name": "RotaTeq™", "type": "BIOLOGICAL" }, { "name": "Pentacel™", "type": "BIOLOGICAL" }, { "name": "RECOMBIVAX HB™", "type": "BIOLOGICAL" }, { "name": "HIBERIX™", "type": "BIOLOGICAL" }, { "name": "M-M-R™ II", "type": "BIOLOGICAL" }, { "name": "VARIVAX™", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "90 Days", "sex": "ALL", "summary": "42 Days to 90 Days" }, "enrollment_count": 900, "start_date": "2018-10-18", "completion_date": "2020-12-14", "has_results": true, "last_update_posted_date": "2023-01-17", "last_synced_at": "2026-10-08T18:12:08.999Z", "location_count": 22, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Jonesboro, Arkansas + 16 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03620162" }, { "nct_id": "NCT04077424", "title": "Senescent Immunity in Elders and Vaccine Responses (SILVER)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Flu Vaccine" ], "interventions": [ { "name": "Fluzone-High Dose Quadrivalent", "type": "BIOLOGICAL" }, { "name": "Fluad", "type": "BIOLOGICAL" }, { "name": "Flublock", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": "125 Years", "sex": "ALL", "summary": "65 Years to 125 Years" }, "enrollment_count": 10, "start_date": "2019-10-21", "completion_date": "2020-02-01", "has_results": true, "last_update_posted_date": "2022-07-12", "last_synced_at": "2026-10-08T18:12:08.999Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT04077424" }, { "nct_id": "NCT06038617", "title": "Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Fever After Vaccination", "Fever", "Seizures Fever" ], "interventions": [ { "name": "mRNA COVID-19 Vaccine", "type": "BIOLOGICAL" }, { "name": "Routine Childhood Vaccinations", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "4 Years", "sex": "ALL", "summary": "6 Months to 4 Years" }, "enrollment_count": 347, "start_date": "2023-10-30", "completion_date": "2025-07-25", "has_results": true, "last_update_posted_date": "2026-05-13", "last_synced_at": "2026-10-08T18:12:08.999Z", "location_count": 5, "location_summary": "Oakland, California • Atlanta, Georgia • New York, New York + 2 more", "locations": [ { "city": "Oakland", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "New York", "state": "New York" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06038617" }, { "nct_id": "NCT04456504", "title": "HepB-CpG Series for Healthcare Workers Who Are Hepatitis B Vaccine Nonresponders", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Healthcare Worker, Hepatitis B Vaccine, Nonresponder" ], "interventions": [ { "name": "Recombinant hepatitis B vaccine with CpG adjuvant", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 49, "start_date": "2020-09-15", "completion_date": "2023-12-06", "has_results": true, "last_update_posted_date": "2024-07-16", "last_synced_at": "2026-10-08T18:12:08.999Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT04456504" }, { "nct_id": "NCT02055365", "title": "Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hepatitis B" ], "interventions": [ { "name": "Hepatitis B Vaccine (Recombinant)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Rockefeller University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 10, "start_date": "2014-02-18", "completion_date": "2015-01-06", "has_results": true, "last_update_posted_date": "2018-05-07", "last_synced_at": "2026-10-08T18:12:08.999Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02055365" }, { "nct_id": "NCT04723602", "title": "Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Ebola Virus Disease", "Marburg Virus Disease" ], "interventions": [ { "name": "cAd3-Marburg", "type": "BIOLOGICAL" }, { "name": "cAd3-EBO-S", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Albert B. Sabin Vaccine Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 32, "start_date": "2021-01-06", "completion_date": "2021-12-14", "has_results": false, "last_update_posted_date": "2022-08-03", "last_synced_at": "2026-10-08T18:12:08.999Z", "location_count": 1, "location_summary": "Oklahoma City, Oklahoma", "locations": [ { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT04723602" } ] }